These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8618209)

  • 1. Controlled release of newer quinolones from biodegradable systems based on poly(lactic acid).
    Andreopoulos AG
    J Biomater Appl; 1995 Oct; 10(2):163-70. PubMed ID: 8618209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro release of new quinolones from biodegradable systems: a comparative study.
    Andreopoulos AG; Korakis T; Dounis E; Anastasiadis A; Tzivelekis P; Kanellakopoulou K
    J Biomater Appl; 1996 Apr; 10(4):338-47. PubMed ID: 8859405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of polylactic acid microcapsules containing ciprofloxacin.
    Yu WP; Wong JP; Chang TM
    J Microencapsul; 1998; 15(4):515-23. PubMed ID: 9651872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained drug release characteristics of biodegradable composite poly(d,l)lactic acid-poly(l)lactic acid microcapsules containing ciprofloxacin.
    Yu WP; Wong JP; Chang TM
    Artif Cells Blood Substit Immobil Biotechnol; 2000 Jan; 28(1):39-55. PubMed ID: 10676576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodegradable microspheres of poly(DL-lactic acid) containing piroxicam as a model drug for controlled release via the parenteral route.
    Lalla JK; Sapna K
    J Microencapsul; 1993; 10(4):449-60. PubMed ID: 8263674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactic acid polymers as biodegradable carriers of fluoroquinolones: an in vitro study.
    Kanellakopoulou K; Kolia M; Anastassiadis A; Korakis T; Giamarellos-Bourboulis EJ; Andreopoulos A; Dounis E; Giamarellou H
    Antimicrob Agents Chemother; 1999 Mar; 43(3):714-6. PubMed ID: 10049299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intravitreal drug delivery by microspheres of biodegradable polymers].
    Moritera T; Ogura Y; Honda Y; Wada R; Hyon SH; Ikada Y
    Nippon Ganka Gakkai Zasshi; 1990 May; 94(5):508-13. PubMed ID: 2220493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained drug delivery systems II: Factors affecting release rates from poly(epsilon-caprolactone) and related biodegradable polyesters.
    Pitt CG; Gratzl MM; Jeffcoat AR; Zweidinger R; Schindler A
    J Pharm Sci; 1979 Dec; 68(12):1534-8. PubMed ID: 529046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodegradable poly(DL-lactic acid) formulations in a calcitonin delivery system.
    Asano M; Yoshida M; Omichi H; Mashimo T; Okabe K; Yuasa H; Yamanaka H; Morimoto S; Sakakibara H
    Biomaterials; 1993 Aug; 14(10):797-9. PubMed ID: 8218732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodegradable tablets having a matrix of low molecular weight poly-L-lactic acid and poly-D,L-lactic acid.
    Moll F; Köller G
    Arch Pharm (Weinheim); 1990 Oct; 323(10):887-8. PubMed ID: 2080895
    [No Abstract]   [Full Text] [Related]  

  • 11. Microencapsulation of lobster carotenoids within poly(vinyl alcohol) and poly(D,L-lactic acid) membranes.
    Sun ZM; Poncelet D; Conway J; Neufeld RJ
    J Microencapsul; 1995; 12(5):495-504. PubMed ID: 8544093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) microcapsules: problems associated with preparative techniques and release properties.
    Jalil R; Nixon JR
    J Microencapsul; 1990; 7(3):297-325. PubMed ID: 2200861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preparation of ibuprofen/sPEG-b-PLLA copolymer microspheres and its in vitro release properties].
    Lin YL; Zhang AQ; Guan FY; Chen YD; Tan WA; Wang LS
    Yao Xue Xue Bao; 2010 Dec; 45(12):1570-5. PubMed ID: 21351499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal delivery of ciprofloxacin.
    Hainsworth DP; Conklin JD; Bierly JR; Ax D; Ashton P
    J Ocul Pharmacol Ther; 1996; 12(2):183-91. PubMed ID: 8773934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug delivery systems using sandwich configurations of electrospun poly(lactic acid) nanofiber membranes and ibuprofen.
    Immich AP; Arias ML; Carreras N; Boemo RL; Tornero JA
    Mater Sci Eng C Mater Biol Appl; 2013 Oct; 33(7):4002-8. PubMed ID: 23910307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodegradation and antitumour effect of adriamycin-containing poly(L-lactic acid) microspheres.
    Ike O; Shimizu Y; Ikada Y; Watanabe S; Natsume T; Wada R; Hyon SH; Hitomi S
    Biomaterials; 1991 Oct; 12(8):757-62. PubMed ID: 1799651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High glycolic poly (DL lactic co glycolic acid) nanoparticles for controlled release of meropenem.
    Nandakumar V; Geetha V; Chittaranjan S; Doble M
    Biomed Pharmacother; 2013 Jun; 67(5):431-6. PubMed ID: 23583192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled protein release from polyethyleneimine-coated poly(L-lactic acid)/pluronic blend matrices.
    Park TG; Cohen S; Langer R
    Pharm Res; 1992 Jan; 9(1):37-9. PubMed ID: 1589407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Progress in the study of pH and temperature sensitive biodegradable block copolymers].
    Hao TN; Qiao MX; Li Z; Chen DW
    Yao Xue Xue Bao; 2008 Feb; 43(2):123-7. PubMed ID: 18507336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biodegradable poly (lactic acid) microspheres for drug delivery systems.
    Hyon SH
    Yonsei Med J; 2000 Dec; 41(6):720-34. PubMed ID: 11204823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.